Lexicon Pharmaceuticals (LXRX) Receivables: 2009-2012
Historic Receivables for Lexicon Pharmaceuticals (LXRX) over the last 4 years, with Sep 2012 value amounting to $233,000.
- Lexicon Pharmaceuticals' Receivables fell 52.35% to $233,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $951,000, marking a year-over-year decrease of 62.98%. This contributed to the annual value of $350,000 for FY2011, which is 52.96% down from last year.
- Per Lexicon Pharmaceuticals' latest filing, its Receivables stood at $233,000 for Q3 2012, which was up 28.02% from $182,000 recorded in Q2 2012.
- In the past 5 years, Lexicon Pharmaceuticals' Receivables registered a high of $2.1 million during Q2 2010, and its lowest value of $182,000 during Q2 2012.
- Its 3-year average for Receivables is $810,182, with a median of $505,000 in 2011.
- In the last 5 years, Lexicon Pharmaceuticals' Receivables skyrocketed by 57.77% in 2010 and then crashed by 77.62% in 2012.
- Quarterly analysis of 4 years shows Lexicon Pharmaceuticals' Receivables stood at $815,000 in 2009, then declined by 8.71% to $744,000 in 2010, then crashed by 52.96% to $350,000 in 2011, then crashed by 52.35% to $233,000 in 2012.
- Its Receivables was $233,000 in Q3 2012, compared to $182,000 in Q2 2012 and $186,000 in Q1 2012.